Trial intelligence / Profile preview

Evaluating Population-Based Strategies for Rural Smoking Cessation

NCT06584929Recruiting

Sponsor
Masonic Cancer Center
Start
Mar 2026
Primary completion
Oct 2028
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of nicotine patch in nicotine dependence (3 arms), sponsored by Masonic Cancer Center. Primary endpoint: Number of participants abstinent from all combustible tobacco products at 3 months. Started Mar 2026; status: recruiting.

02

Drugs

nicotine patch
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT06584929.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06584929.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call